Login / Signup

Freeing the Competition: Will Aumolertinib (AENEAS) Have a Fighting Chance Against Osimertinib (FLAURA)?

David J BenjaminMisako Nagasaka
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Keyphrases
  • small cell lung cancer
  • advanced non small cell lung cancer
  • epidermal growth factor receptor
  • tyrosine kinase